Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$15,350,306
+$3,792,477 QoQ
Shares Held
12,798
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#1,025
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. LLY ranks #1 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
|
26,087 | $4,088,354 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,350,306 | 12,798 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $11,557,829 | 12,566 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $13,519,475 | 12,580 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,855,671 | 12,917 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $9,716,841 | 12,465 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $10,238,806 | 12,397 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $9,558,132 | 12,381 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $11,142,467 | 12,577 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $11,570,756 | 12,780 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $10,368,650 | 13,328 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $7,946,948 | 13,633 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $7,665,919 | 14,272 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $6,889,316 | 14,690 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,581,566 | 13,341 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $4,926,401 | 13,466 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $4,470,637 | 13,826 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,534,032 | 13,984 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,006,029 | 13,989 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $3,877,576 | 14,038 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,267,740 | 14,143 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,313,580 | 14,437 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,701,604 | 14,461 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,479,584 | 14,686 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,229,181 | 15,060 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,464,177 | 15,009 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,083,296 | 15,018 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||